Attached files
file | filename |
---|---|
EX-99.1 - EXHIBIT 99.1 - Foundation Healthcare, Inc. | c09029exv99w1.htm |
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 19, 2010
Graymark Healthcare,
Inc.
(Exact name of registrant as
specified in its charter)
Oklahoma | 001-34171 | 20-0180812 | ||
(State or other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
210 Park Avenue, Suite
1350 Oklahoma City, Oklahoma |
73102 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (405) 601-5300
(Former name or former address if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
(b) | Pro Forma Financial Information. |
(d) | Exhibits. |
Exhibit No. | Description | |
10.1+
|
Asset Purchase Agreement dated September 1, 2010 among Walgreen Co., ApothecaryRx, LLC, and, to certain sections only, Graymark Healthcare, Inc. (incorporated by reference to Exhibit No. 10.1 to registrants current report on Form 8-K filed September 2, 2010) | |
10.2
|
First Amendment to Asset Purchase Agreement dated October 29, 2010 among Walgreen Co., ApothecaryRx, LLC, and, to certain sections only, Graymark Healthcare, Inc. (incorporated by reference to Exhibit No. 10.1 to registrants current report on Form 8-K filed October 29, 2010) | |
99.1
|
Unaudited pro forma condensed combined financial information of Registrant. |
+ | The schedules and exhibits to the Asset Purchase Agreement are not being filed herewith. The Asset Purchase Agreement contains a list briefly identifying the contents of the schedules and exhibits to such document. The Registrant undertakes to furnish supplementally a copy of any omitted schedule and exhibit to the Securities and Exchange Commission upon request. |
By: | GRAYMARK HEALTHCARE, INC. | |||
Date: November 26, 2010 | By: | /S/ Stanton Nelson | ||
Stanton Nelson | ||||
Chief Executive Officer |
Exhibit No. | Description | |
10.1
|
Asset Purchase Agreement dated September 1, 2010 among Walgreen Co., ApothecaryRx, LLC, and, to certain sections only, Graymark Healthcare, Inc. (incorporated by reference to Exhibit No. 10.1 to registrants current report on Form 8-K filed September 2, 2010) | |
10.2
|
First Amendment to Asset Purchase Agreement dated October 29, 2010 among Walgreen Co., ApothecaryRx, LLC, and, to certain sections only, Graymark Healthcare, Inc. (incorporated by reference to Exhibit No. 10.1 to registrants current report on Form 8-K filed October 29, 2010) | |
99.1
|
Unaudited pro forma condensed combined financial information of Registrant. |